http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-560252-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cc2115df44bc4bd8f281c4297bfa686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d10004842739b6412a902db95ef3c296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2006-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4fda8dcbef6ae5a10121be52155aee3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e6f4b335ee449f7964ed897dcd0e96a |
| publicationDate | 2009-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-560252-A |
| titleOfInvention | Novel pyrimidine nucleoside compound or its salt |
| abstract | Disclosed are 2'-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine derivatives or a salt thereof represented by the formula (1), wherein one of X and Y represents a cyano group, and the other represents a hydrogen atom; one of R1 and R2 represents a hydrogen atom, a carbonyl group having a C1-C6alkyl group which has been mono-substituted by an amino group or a group represented by (R3)(R4)(R5)Si-, and the other represents a group represented by (R6)(R7)(R8)Si-, or R1 and R2 together form a six-membered cyclic group represented by -Si(R9)(R10) -, where the other substituents are defined herein. Also disclosed is a drug composition which contains an effective amount of a pyrimidine nucleoside compound as defined above or a salt thereof and a pharmaceutically acceptable carrier. Additionally, the use of a pyrimidine nucleoside compound as defined above for production of a drug for use as an anti-tumor agent is also disclosed. |
| priorityDate | 2005-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.